Here we have down-regulated HTT levels using antisense oligonucleotides and shown that despite a robust HTT knockdown was achieved in both control and HD neurons, only observed subtle changes in the RAN N/C ratio either in MAP2 or DARPP32 -positive neurons, suggesting that some active transport deficits remain. The gene discussed is HTT; the disease is Huntington disease.